World Antitumor Drug Market Research Report (～2027)
Global Antitumor Drug Market (up to 2027): By Disease, By Route of Administration, By Drug, By Drug Classification, By End User, By Distribution Channel, By Region
360iResearch predicts that the global market size for antitumor drugs, which was $27.8 billion in 2021, will reach $31.13 billion in 2022 and expand to $55.3 billion by 2027, growing at a CAGR of 12.14%. This research report analyzes the global market for antitumor drugs from multiple perspectives, including an introduction, research methodology, executive summary, market overview, market insights, disease-specific analysis (breast cancer, leukemia, lung cancer, melanoma, prostate cancer), route of administration analysis (intramuscular, intraperitoneal, intravenous, intraventricular/intrathecal, intravesical), drug class analysis (alkylating agents, antimetabolites, antitumor antibiotics, mitotic inhibitors, topoisomerase inhibitors), end-user analysis (clinics, hospitals, specialty centers), regional analysis (North and South America, United States, Canada, Brazil, Asia-Pacific, Japan, China, India, South Korea, Taiwan, Europe/Middle East/Africa, United Kingdom, Germany, France, Russia, others), competitive landscape, and company information.
- Company：マーケットリサーチセンター
- Price：Other
